Mon Sep 23 17:42:56 UTC 2024: ## Wall Street Adjusts Price Targets for Dozens of Stocks

**New York, NY – September 23, 2024** – A wave of price target adjustments swept across Wall Street on Monday, affecting a diverse range of companies from healthcare to technology. Here are some of the most notable changes:

**Upgraded Targets:**

* **Addus HomeCare (ADUS)** received a price target increase from Oppenheimer Holdings Inc., moving from $140.00 to $145.00. The firm maintains an “outperform” rating.
* **Applied Industrial Technologies (AIT)** saw its target price raised by KeyCorp from $215.00 to $245.00, with the firm holding an “overweight” rating.
* **Ameresco (AMRC)** saw a positive adjustment from Robert W. Baird, boosting the target price from $32.00 to $42.00. Baird remains “outperform” on the stock.
* **American Tower (AMT)** received a price target upgrade from JPMorgan Chase & Co., raising it from $240.00 to $250.00. The firm holds an “overweight” rating.
* **Ascendis Pharma A/S (ASND)** saw its target price boosted by Bank of America Co., moving from $175.00 to $191.00. The firm retains a “buy” rating.

**Downgraded Targets:**

* **Ally Financial (ALLY)** saw a target price reduction from TD Cowen, decreasing from $45.00 to $37.00. The firm maintains a “hold” rating.
* **Apellis Pharmaceuticals (APLS)** experienced a lowered target price from Robert W. Baird, falling from $96.00 to $92.00. Baird still holds an “outperform” rating.
* **Aptevo Therapeutics (APVO)** saw a significant reduction in its target price from Roth Mkm, dropping from $15.00 to $8.00. The firm retains a “buy” rating.

These are just a few examples of the many price target changes that occurred on Monday. It is important to note that these adjustments are based on analysts’ interpretations of a company’s current performance, future prospects, and overall market conditions. While these changes can provide valuable insights, investors should conduct their own due diligence before making any investment decisions.

**To stay updated on the latest news and analyst ratings for Addus HomeCare Co and related companies, sign up for MarketBeat.com’s FREE daily email newsletter.**

Read More